A WELL-CONTROLLED, FIXED-DOSE STUDY OF TEV-50717 (DEUTETRABENAZINE) FOR THE TREATMENT OF TICS ASSOCIATED WITH TOURETTE SYNDROME

Registry ID

TV50717-CNS-30060

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC

Last update

2019-01-17

Conditions

• TOURETTE¿S SYNDROME

Related clinical trials

• AN OPEN-LABEL, LONG-TERM SAFETY STUDY INCLUDING A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL PERIOD OF TEV-50717 (DEUTETRABENAZINE) FOR THE TREATMENT OF TOURETTE SYNDROME IN CHILDREN AND ADOLESCENTS
• A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER PILOT TRIAL OF MEDICAL CANNABIS IN ADULTS WITH TOURETTE SYNDROME.

View on source registry